448 related articles for article (PubMed ID: 26075890)
21. [Comparison of HBV persistent infection mice models by different serotypes of AAVs carrying HBV genomes].
Zhu X; Zhou Q; Tian W; Liu C; Dong X; Wu X; Yu C
Sheng Wu Gong Cheng Xue Bao; 2015 Dec; 31(12):1764-72. PubMed ID: 27093839
[TBL] [Abstract][Full Text] [Related]
22. [Anti-HBV effect of nucleotide analogues on mouse model of chronic HBV infection mediated by recombinant adeno-associated virus 8].
Wang G; Wang G; Dong X; Tian W; Yuchi J; Wei G; Meng H; Wu X
Sheng Wu Gong Cheng Xue Bao; 2013 Jan; 29(1):95-106. PubMed ID: 23631122
[TBL] [Abstract][Full Text] [Related]
23. PD-1 mRNA expression is associated with clinical and viral profile and PD1 3'-untranslated region polymorphism in patients with chronic HBV infection.
Zhang G; Li N; Zhang P; Li F; Yang C; Zhu Q; Han Q; Lv Y; Zhou Z; Liu Z
Immunol Lett; 2014 Nov; 162(1 Pt A):212-6. PubMed ID: 25218665
[TBL] [Abstract][Full Text] [Related]
24. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
Toyoda H; Kumada T; Kaneoka Y; Murakami Y
J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
[TBL] [Abstract][Full Text] [Related]
25. A mouse model for HBV immunotolerance and immunotherapy.
Yang D; Liu L; Zhu D; Peng H; Su L; Fu YX; Zhang L
Cell Mol Immunol; 2014 Jan; 11(1):71-8. PubMed ID: 24076617
[TBL] [Abstract][Full Text] [Related]
26. Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells.
Jin Z; Sun R; Wei H; Gao X; Chen Y; Tian Z
Hepatology; 2011 Jan; 53(1):219-29. PubMed ID: 21140473
[TBL] [Abstract][Full Text] [Related]
27. Natural history of chronic hepatitis B: what exactly has REVEAL revealed?
Iloeje UH; Yang HI; Chen CJ
Liver Int; 2012 Oct; 32(9):1333-41. PubMed ID: 22510145
[TBL] [Abstract][Full Text] [Related]
28. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
[TBL] [Abstract][Full Text] [Related]
29. Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients.
Al-Qahtani AA; Al-Anazi M; Abdo AA; Sanai FM; Al-Hamoudi W; Alswat KA; Al-Ashgar HI; Khalaf N; Viswan N; Al-Ahdal MN
Exp Mol Pathol; 2013 Dec; 95(3):255-8. PubMed ID: 23994040
[TBL] [Abstract][Full Text] [Related]
30. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
31. [Distribution of hepatitis B virus genotypes and its clinical significance in Guangxi].
Ge XM; Li DY; Fang ZL; Huang GY; Jiang SQ; Pan HD; Du Y; Wang CY; Ding X; Masashi M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):174-9. PubMed ID: 12870004
[TBL] [Abstract][Full Text] [Related]
32. The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity.
Li MS; Lau TC; Chan SK; Wong CH; Ng PK; Sung JJ; Chan HL; Tsui SK
PLoS One; 2011; 6(7):e21856. PubMed ID: 21814558
[TBL] [Abstract][Full Text] [Related]
33. Differential integration rates of hepatitis B virus DNA in the liver of children with chronic hepatitis B virus infection and hepatocellular carcinoma.
Huang HP; Tsuei DJ; Wang KJ; Chen YL; Ni YH; Jeng YM; Chen HL; Hsu HY; Chang MH
J Gastroenterol Hepatol; 2005 Aug; 20(8):1206-14. PubMed ID: 16048568
[TBL] [Abstract][Full Text] [Related]
34. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
Tseng TC; Liu CJ; Chen PJ; Lai MY; Lin CL; Kao JH; Chen DS
Liver Int; 2007 Sep; 27(7):983-8. PubMed ID: 17696938
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA.
Sekiba K; Otsuka M; Ohno M; Yamagami M; Kishikawa T; Suzuki T; Ishibashi R; Seimiya T; Tanaka E; Koike K
World J Gastroenterol; 2018 Jun; 24(21):2261-2268. PubMed ID: 29881235
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection.
Giersch K; Allweiss L; Volz T; Helbig M; Bierwolf J; Lohse AW; Pollok JM; Petersen J; Dandri M; Lütgehetmann M
J Hepatol; 2015 Aug; 63(2):346-53. PubMed ID: 25795587
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells.
Ren X; Luo G; Xie Z; Zhou L; Kong X; Xu A
J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826
[TBL] [Abstract][Full Text] [Related]
38. Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B.
Mathai AM; Alexander J; Kuo FY; Torbenson M; Swanson PE; Yeh MM
Hum Pathol; 2013 Aug; 44(8):1665-71. PubMed ID: 23574780
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
Lin CL; Kao JH
J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
[TBL] [Abstract][Full Text] [Related]
40. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
